scholarly journals Comparing international approaches to food safety regulation of GM and Novel Foods

2021 ◽  
Author(s):  

The global area of genetically modified (GM) crop production has considerably increased over the past two decades, with GM crops now cultivated in about 28 countries, accounting for over 10% of the world’s arable land. A 'novel food' is any food or substance that has not been used for human consumption to a significant degree within the EU before 15 May 1997. Since then, there has been over 90 novel foods authorisations approved for use by the EU. Novel foods and genetically modified organisms (GMOs) are subject to a large variation in regulatory approaches around the world, for which many countries have specifically developed their own regulatory frameworks to control the placement of such products on their markets.

2021 ◽  
Vol 13 (9) ◽  
pp. 5065
Author(s):  
Margherita Paola Poto ◽  
Mathilde D. Morel

“Novel food” in the European Union’s (EU) legal terms refers to any food that was not used for human consumption to a significant degree within the EU before 15 May 1997 (Regulation 2015/2283/EU (2015)). Placing novel food on the market requires a safety assessment when such novelty is ascertained, with the consequent need of an authorization procedure that is not required for food traditionally conceived in the EU. Studies have highlighted how such a Eurocentric proof of traditional/novel use of food results in unequal treatment of third countries, with a slowdown of their market investments in the EU market. This contribution addresses this aspect by critically examining the disparity of treatment and suggesting the adoption of a wide-ranging interpretation of food novelty that considers the biocultural context in which food is embedded. This work is based on a critical legal analysis through the hermeneutics of Reg. 2015/2283/EU (2015) and a case study on algae from Northern Norway and Sápmi, carried out by the project SECURE. We conclude that a legal interpretation connecting food to its biocultural context would contribute to qualify it as traditional and therefore facilitate its placement on the market. Our case study provides an example of the macroalgae collected in Northern Norway/Sápmi that through the criterion of the biocultural context would qualify as traditional food, without recourse to the authorization procedure. Further research could assess whether the European Commission’s list of authorized novel foods (which include algae whose status as novel food has been inquired and assessed) expands to also comprehend some of the low-trophic marine resources (LTMR) harvested in Northern Norway/Sápmi.


2016 ◽  
Vol 46 (5) ◽  
pp. 620-627
Author(s):  
Roberto Defez

Purpose The debate around the use and study of genetically modified organisms (GMOs) is so complex that frequently people miss that the outcome of some political/social/economic decisions are taken in such a way that the legal/agricultural/medical coherence is lost. The purpose of this text is to underline the contradictions in the European approach to GMOs, when for the past 20 years the European Union (EU) has been using and importing GMOs but rejecting its study or cultivation. Design/methodology/approach The approach follows the distance among public declarations against GMOs from most of the political representatives, followed by decision on our health, nutrition and economic development going exactly in the opposite direction. The arrival of the new genome-edited plants cannot solve all requirements, as in many cases an entire new function should be added and, at present, this will be again a GMO irrespective to the technique used to add a new gene. The delay in taking these decisions are now posing a hazard on the cultural and economic development of the EU. Findings The laws (directives) on GMOs in the EU are far too restrictive and suffer from an over-regulation that prevent any attempt to come to a science-based approach on genetically modified (GM) plants. The basis for the definition and the restrictions is on the technology and not on the final product. However, on the other hand, the GMOs are the only product where the safety analysis is on the final product (which is not the case for organics productions). The paradox is that all restrictions are concentrated on GM plants to be cultivated in Europe, as if the main hazard would be on the environmental impact of local cultivation. Meanwhile, the EU has no concern if the same environmental damage happens abroad and EU is the final user of the technology as 68 different GMOs are imported and used even for human consumption in Europe. Originality/value Fighting against the EU over-regulation would appear to be a position supporting multinational seed companies (none of them based in the EU), described as polluters. The proposed approach is the opposite, asking for a more restrictive regulation to show to the consumers that: most local EU high quality food products are derived from GM-fed animals; GM cotton is potentially far more risky than any GM food; and reducing GM plants cultivated in Europe increases the pesticide sold by chemical companies (mostly based in the EU).


2004 ◽  
Vol 5 (2) ◽  
pp. 151-166 ◽  
Author(s):  
Patrycja Dąbrowska

Almost exactly one year after the famous judgments of the Court of First Instance on the precautionary principle, the European Court of Justice (hereinafter “the Court”) has issued a preliminary ruling further exploring this concept. The ruling arose from a national dispute concerning a temporary ban on novel foods produced from genetically modified organisms (hereinafter “GMOs”). This recent Monsanto judgment is the first case in which the Court has directly invoked the precautionary principle regarding Member States’ power to adopt a provisional prohibition on the marketing of GMO-derived novel foods. Simultaneously, the Court lent an ear to the arguments of Monsanto by declaring the validity of the simplified procedure laid down in the novel foods Regulation 258/97 and based on the contentious concept of substantial equivalence. Thus, it seems to have favoured the free circulation in the Community market of novel foodstuffs notwithstanding the presence of residues of genetically modified (hereinafter “GM”) protein, on the condition that there is no risk to human health.


2015 ◽  
Vol 12 (113) ◽  
pp. 20150891 ◽  
Author(s):  
Christian Schader ◽  
Adrian Muller ◽  
Nadia El-Hage Scialabba ◽  
Judith Hecht ◽  
Anne Isensee ◽  
...  

Increasing efficiency in livestock production and reducing the share of animal products in human consumption are two strategies to curb the adverse environmental impacts of the livestock sector. Here, we explore the room for sustainable livestock production by modelling the impacts and constraints of a third strategy in which livestock feed components that compete with direct human food crop production are reduced. Thus, in the outmost scenario, animals are fed only from grassland and by-products from food production. We show that this strategy could provide sufficient food (equal amounts of human-digestible energy and a similar protein/calorie ratio as in the reference scenario for 2050) and reduce environmental impacts compared with the reference scenario (in the most extreme case of zero human-edible concentrate feed: greenhouse gas emissions −18%; arable land occupation −26%, N-surplus −46%; P-surplus −40%; non-renewable energy use −36%, pesticide use intensity −22%, freshwater use −21%, soil erosion potential −12%). These results occur despite the fact that environmental efficiency of livestock production is reduced compared with the reference scenario, which is the consequence of the grassland-based feed for ruminants and the less optimal feeding rations based on by-products for non-ruminants. This apparent contradiction results from considerable reductions of animal products in human diets (protein intake per capita from livestock products reduced by 71%). We show that such a strategy focusing on feed components which do not compete with direct human food consumption offers a viable complement to strategies focusing on increased efficiency in production or reduced shares of animal products in consumption.


2020 ◽  
Vol 7 (1) ◽  
Author(s):  
Trace Agostino ◽  
Amanda Trukus ◽  
Micheal Jain

The use of genetically modified organisms (GMO) in food is a highly public and controversial issue. We have used an enzyme-linked immunosorbent assay (ELISA) to detect the genetically modified protein 5-enol-pyruvylshikimate-3-phosphate (EPSP) synthase within soy-containing food products from the grocery store. We found that EPSP synthase is detectable in 3 out of 5 food products tested. Of specific interest, we found contamination levels of EPSP synthase (0.36%) in Heinz' Pablum Soya Cereal, which is currently deemed to be free of genetic modifications by the company as well as by Greenpeace Canada. These results demonstrate that genetically modified organisms are present in foods commonly available for human consumption and that the widespread use of this technology may make it difficult to ensure that any given product is free of all traces of genetically modified protein.


Afrika Focus ◽  
2019 ◽  
Vol 32 (2) ◽  
Author(s):  
G. Gheysen ◽  
J. Maes ◽  
M. Valcke ◽  
E.I.R. Sanou ◽  
S. Speelman ◽  
...  

Genetically modified (GM) crops are cultivated globally on more than 185 million hectares, but the use of GM crops in Europe and Africa is very limited. Politicians are reluctant to allow such crops because they fear negative public reaction. The political hostility in the EU towards GM crops also has a significant impact on how African policy makers form their opinions for accepting GM crops in their own countries. However, studies reveal that specific types of GM food are welcomed by consumers and that few Europeans avoid GM labels when buying food. Similarly, African farmers and consumers are generally positive about GM crops. Policy makers should take these results into account when a decision needs to be made on whether or not to allow GM crop cultivation in their country. KEY WORDS: ACCEPTANCE, AFRICA, CONSUMERS, EUROPE, FARMERS, GM CROPS


2020 ◽  
Vol 21 (1) ◽  
pp. 11-20
Author(s):  
Anisa ◽  
Chelsilya ◽  
Grace Yohana ◽  
Mucco Eva ◽  
Morry Zefanya ◽  
...  

Current technological advances have been present in all aspects of human life, including technological advances in biotechnology. Biotechnology not only raises hope for science but also raises heated debates among scientists, especially between the European Union and the US. This debate arises because of differences in perspective between the EU and the US. The EU has stringent rules regarding the development efforts of genetically modified organisms (GMOs). At the same time, the US thinks that GMOs are part of agriculture, so there is no need for any special laws to regulate them. Various side effects also come hand in hand with the birth of GMOs. They are ranging from adverse effects on human health, the health of food products, and even environmental damage. The development of GMOs can damage the ecosystem of species that exist in the environment. Still, more complex problems arise due to GMOs like economic problems and monopolies.   Keywords: The  GMOs, The EU, The US.


Sign in / Sign up

Export Citation Format

Share Document